Cargando…
The “Magic Bullet” Is Here? Cell-Based Immunotherapies for Hematological Malignancies in the Twilight of the Chemotherapy Era
Despite the introduction of a plethora of different anti-neoplastic approaches including standard chemotherapy, molecularly targeted small-molecule inhibitors, monoclonal antibodies, and finally hematopoietic stem cell transplantation (HSCT), there is still a need for novel therapeutic options with...
Autores principales: | Miazek-Zapala, Nina, Slusarczyk, Aleksander, Kusowska, Aleksandra, Zapala, Piotr, Kubacz, Matylda, Winiarska, Magdalena, Bobrowicz, Malgorzata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232692/ https://www.ncbi.nlm.nih.gov/pubmed/34203935 http://dx.doi.org/10.3390/cells10061511 |
Ejemplares similares
-
Molecular Aspects of Resistance to Immunotherapies—Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma
por: Kusowska, Aleksandra, et al.
Publicado: (2022) -
In Vitro Diffuse Large B-Cell Lymphoma Cell Line Models as Tools to Investigate Novel Immunotherapeutic Strategies
por: Kubacz, Matylda, et al.
Publicado: (2022) -
CD37 in B Cell Derived Tumors—More than Just a Docking Point for Monoclonal Antibodies
por: Bobrowicz, Malgorzata, et al.
Publicado: (2020) -
Selective inhibition of HDAC6 sensitizes cutaneous T-cell lymphoma to PI3K inhibitors
por: Bobrowicz, Malgorzata, et al.
Publicado: (2020) -
The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: a systematic review and meta-analysis
por: Ślusarczyk, Aleksander, et al.
Publicado: (2022)